Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ESP vs VREX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ESP Captures Overall Composite Edge (39.8 SELL vs 54.8 HOLD), While VREX Leads 3–2 on Growth & Valuation Pillars

ESP Overall Winner 6-Pillar Tally: ESP 2 – 3 VREX (1 Tie) Matrix Metrics: ESP 6 – 4 VREX

As of Nov 20, 2026, Espey Mfg. & Electronics Corp (ESP) captures the overall head-to-head institutional edge over Varex Imaging Corporation (VREX) on higher Unified Composite conviction (39.8/100 SELL vs. 54.8/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while VREX wins 3–2 across the 6-pillar growth and valuation breakdown. ESP trades at $37.03 (10.0x Forward P/E, 24.4% operating margin) versus VREX at $18.10 (16.9x Forward P/E, 8.3% operating margin).

  • Composite vs. Pillar Nuance: While VREX currently prints a higher short-term Unified Composite Score (54.8/100 HOLD vs. ESP 39.8/100 SELL), ESP captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (24.4% vs. 8.3% operating margin) and revenue trajectory (+16.7% vs. +3.7% YoY).
  • Technical & Structure Timing Caution: ESP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.9); meanwhile VREX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 28.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ESP vs VREX
ESP NYSE American Head-to-Head Winner
Espey Mfg. & Electronics Corp
Electronic Components, Nec
$37.03
-5.05% 1D
Market Cap $112.2M
TTM Revenue $48M
Forward P/E 10.0x
Beta / 30D Vol 1.38β · 67% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.1%), weak momentum, RSI 22
RSI-14: 21.9 · SMA20: $47.62 · SMA50: $55.28
VREX NASDAQ
Varex Imaging Corporation Common Stock
Electronic Components, Nec
$18.10
-0.22% 1D
Market Cap $770.3M
TTM Revenue $865M
Forward P/E 16.9x
Beta / 30D Vol 0.65β · 5% Vol
Unified Composite Score
54.8 / 100 HOLD
Tech 46.0 Fund 45.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.3%) with fading momentum, RSI 28
RSI-14: 28.4 · SMA20: $18.34 · SMA50: $18.41

6-Pillar Scorecard Institutional Category Breakdown (ESP 2 – 3 VREX)

Columns: Metric · ESP · VREX
1. Valuation Multiples ESP
Forward P/E 10.0x 16.9x
Trailing P/E 10.1x 34.2x
PEG Ratio N/M 6.30x
EV / Revenue 2.4x 0.9x
2. Growth & Scale VREX
Revenue Growth (YoY) +16.7% +3.7%
Earnings Growth (YoY) -1.3% +453.4%
TTM Revenue (USD) $48M $865M
Market Cap $112.2M $770.3M
3. Profitability & Quality ESP
Gross Margin 34.2% 34.3%
Operating Margin 24.4% 8.3%
Net Profit Margin 23.5% 2.6%
Return on Equity (ROE) 20.1% 4.6%
4. Balance Sheet & Cash Flow VREX
Cash Generation (TTM) $4.4M $100M EBITDA
Cash Flow Margin 9.3% 11.5% EBITDA Mgn
Net Cash / Leverage $21.05 Book/Sh · 20.1% ROE $11.78 Book/Sh · 4.6% ROE
Dividend Yield 2.43% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 112.0% (18th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat VREX
OpEx & R&D Intensity 9.8% of Rev ($4.7M) 26.0% of Rev ($225M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Electrical Equipment & Parts Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ESP (6) vs VREX (4)
Institutional Metric ESP VREX Criterion Row Edge
Market Capitalization
Scale
$112.2M $770.3M Larger Scale VREX
Trailing P/E Ratio
Valuation
10.1x 34.2x Lower Multiple ESP
Forward P/E Ratio
Valuation
10.0x 16.9x Lower Multiple ESP
Revenue Growth (YoY)
Growth
+16.7% +3.7% Higher Growth ESP
Operating Margin (TTM)
Profitability
24.4% 8.3% Higher Margin ESP
Net Profit Margin
Profitability
23.5% 2.6% Higher Margin ESP
Return on Equity (ROE)
Capital Efficiency
20.1% 4.6% Higher ROE ESP
52-Week Range Position
Momentum
1% ($37–$75) 94% ($9–$19) Stronger Trend VREX
Beta / 30D Volatility
Risk Regime
1.38β · 67% Vol 0.65β · 5% Vol Lower Realized Risk VREX
Unified Institutional Score
Composite Signal
39.8 / 100 (SELL) 54.8 / 100 (HOLD) Higher Composite VREX
Trailing 12M Revenue (USD)
Operating Scale
$48M $865M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
34.2% 34.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.4x EV/Rev 6.30x PEG · 0.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$4.4M ($21.05 Book/Sh · 20.1% ROE) $100M EBITDA ($11.78 Book/Sh · 4.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VREX +26.07 pp
ESP: -27.75% · VREX: -1.68%
3M Horizon VREX +39.03 pp
ESP: -41.3% · VREX: -2.27%
6M Horizon VREX +115.45 pp
ESP: -35.71% · VREX: +79.74%
1Y Horizon VREX +80.95 pp
ESP: -4.19% · VREX: +76.76%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ESP vs VREX. Trailing 12-month operating profitability (ESP 24.4% vs VREX 8.3%) and valuation multiples (ESP 10.0x vs VREX 16.9x Forward P/E) are benchmarked directly in Pillar 4 below.

ESP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$48M
Gross Margin34.2%
Op. Margin24.4%
ROE / Fwd P/E20.1% · 10.0x
VREX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$865M
Gross Margin34.3%
Op. Margin8.3%
ROE / Fwd P/E4.6% · 16.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ESP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ESP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VREX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 112.0%
IV Percentile 18th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VREX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ESP Moat Profile Scale & Operating Efficiency Moat
Electrical Equipment & Parts Operator
Competes within the Electrical Equipment & Parts value chain with $112.2M market capitalization and 24.4% operating margin.
OpEx & R&D Reinvestment 9.8% of Rev ($4.7M)
90D Engineering Disclosures 0 Published
VREX Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $770.3M market capitalization and 8.3% operating margin.
OpEx & R&D Reinvestment 26.0% of Rev ($225M)
90D Engineering Disclosures 0 Published

Investor FAQ ESP vs VREX Key Questions & Quantitative Answers

As of Nov 20, 2026, Espey Mfg. & Electronics Corp (ESP) captures the overall head-to-head institutional edge over Varex Imaging Corporation (VREX) on higher Unified Composite conviction (39.8/100 SELL vs. 54.8/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while VREX wins 3–2 across the 6-pillar growth and valuation breakdown. ESP trades at $37.03 (10.0x Forward P/E, 24.4% operating margin) versus VREX at $18.10 (16.9x Forward P/E, 8.3% operating margin). Composite vs. Pillar Nuance: While VREX currently prints a higher short-term Unified Composite Score (54.8/100 HOLD vs. ESP 39.8/100 SELL), ESP captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (24.4% vs. 8.3% operating margin) and revenue trajectory (+16.7% vs. +3.7% YoY). Technical & Structure Timing Caution: ESP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.9); meanwhile VREX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 28.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VREX leads the Growth & Scale pillar: ESP posts +16.7% YoY revenue growth and -1.3% YoY earnings growth on $48M TTM revenue (34.2% gross margin, 24.4% operating margin), compared with VREX at +3.7% YoY revenue growth and +453.4% YoY earnings growth on $865M TTM revenue (34.3% gross margin, 8.3% operating margin). On trailing 12-month operating scale, ESP generates $48M in USD-normalized revenue versus $865M for VREX. In operating R&D and SG&A reinvestment, ESP deploys 9.8% of Rev ($4.7M) (0 90-day corporate R&D disclosures) versus 26.0% of Rev ($225M) (0 disclosures) for VREX.

ESP screens cheaper on headline valuation multiples. ESP trades at 10.0x Forward P/E, 10.1x Trailing P/E, N/M PEG, and 2.4x EV/Revenue (9.3% FCF margin), whereas VREX trades at 16.9x Forward P/E, 34.2x Trailing P/E, 6.30x PEG, and 0.9x EV/Revenue (11.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ESP (20.1% ROE) versus VREX (4.6% ROE) capital efficiency.

In options market volatility and institutional positioning, ESP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.38β · 67% Vol realized risk). By comparison, VREX carries 112.0% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.65β · 5% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.